This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Cano Health Dividende

Dividende contrôle des critères 0/6

Cano Health does not have a record of paying a dividend.

Informations clés

n/a

Rendement du dividende

n/a

Ratio de distribution

Rendement moyen de l'industrie	1.6%
Prochaine date de paiement du dividende	n/a
Date ex-dividende	n/a
Dividende par action	n/a
Résultat par action	-US$207.63
Prévision de rendement du dividende	0%

Mises à jour récentes des dividendes

Pas de mise à jour

Recent updates

Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy

Feb 06

Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations

Aug 11

Cano Health: CEO Departure Could Be Constructive, New Skipper More So

Jun 20

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Jun 09

Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report

May 12

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: Insufficient data to determine if CANO.Q's dividends per share have been stable in the past.

Dividende croissant: Insufficient data to determine if CANO.Q's dividend payments have been increasing.

Rendement des dividendes par rapport au marché

Cano Health Rendement des dividendes par rapport au marché

Comment le rendement du dividende de CANO.Q se compare-t-il à celui du marché ?
Segment	Rendement du dividende
Entreprise (CANO.Q)	n/a
25% du marché (US)	1.4%
25% du marché (US)	4.3%
Moyenne du secteur (Healthcare)	1.6%
Analyste prévisionnel (CANO.Q) (jusqu'à 3 ans)	0%

Dividende notable: Unable to evaluate CANO.Q's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Dividende élevé: Unable to evaluate CANO.Q's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Bénéfice distribué aux actionnaires

Couverture des revenus: Insufficient data to calculate CANO.Q's payout ratio to determine if its dividend payments are covered by earnings.

Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as CANO.Q has not reported any payouts.

This company listing is no longer active

Cano Health Dividende

Dividende contrôle des critères 0/6

Informations clés

Mises à jour récentes des dividendes

Recent updates

First Motion for Exclusivity Period Extension Approved For Cano Health, Inc.

Fourth Amended Disclosure Statement Approved for Cano Health, Inc.

Fourth Amended Reorganization Joint Plan and Disclosure Statement Filed by Cano Health, Inc.

Third Amended Reorganization Joint Plan and Disclosure Statement Filed by Cano Health, Inc.

Second Amended Reorganization Plan and Disclosure Statement Filed by Cano Health, Inc.

First Amended Joint Reorganization and Disclosure Statement Plan Filed by Cano Health, Inc.

Motion for De Minimis Asset Sale Approved for Cano Health, Inc.

Cano Health, Inc. announced delayed annual 10-K filing

Interim DIP Financing Approved for Cano Health, Inc.

Motion for Joint Administration Filed by Cano Health, Inc.

NYSE to Commence Delisting Proceedings Against Cano Health

Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy

Cano Health, Inc. Filed for Bankruptcy

Cano Health Announces Appointment of Two New Independent Directors

Cano Health, Inc. announced delayed 10-Q filing

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Third quarter 2023 earnings released: US$91.87 loss per share (vs US$23.34 loss in 3Q 2022)

High number of new and inexperienced directors

Cano Health Provides Nasdaq Compliance Update

Cano Health, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Cano Health, Inc. Announces the Resignation of Mark Novell as Chief Accounting Officer

Cano Health Receives NYSE Notification Letter; Plans to Regain Compliance with Listing Rules

Cano Health, Inc. Appoints Mark Kent as Chief Executive Officer

Cano Health, Inc. announced delayed 10-Q filing

Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations

Price target decreased by 7.4% to US$2.67

Cano Health, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Cano Health, Inc. Announces Board Changes

Chief Clinical Officer recently sold US$709k worth of stock

Chief Clinical Officer notifies of intention to sell stock

Elliot Cooperstone Issues a Response to Cano Health’s Post-Market Announcement

Cano Health: CEO Departure Could Be Constructive, New Skipper More So

New minor risk - Insider selling

Cano Health, Inc. Announces Chief Executive Officer Changes

Chief Clinical Officer recently sold US$1.2m worth of stock

Cano Health, Inc. Announces Announces Chief Executive Officer Changes

Chief Clinical Officer notifies of intention to sell stock

Elliot Cooperstone Posts Materials to his Website

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Cano Health, Inc. Appoints Frederick Green as Interim Chief Legal Officer

Cano Health, Inc., Annual General Meeting, Jun 15, 2023

Consensus estimates of losses per share improve by 29%

Elliot Cooperstone Sends a Letter to the Shareholders of Cano Health, Inc

Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report

Stabilité et croissance des paiements

Rendement des dividendes par rapport au marché

Bénéfice distribué aux actionnaires

Paiement en espèces aux actionnaires

Découvrir des entreprises qui versent des dividendes élevés